Country operational research priorities pending.
What is the most appropriate method to evaluate the presence of W. bancrofti transmission in urban conurbations to establish if MDA is necessary for LF elimination?
This social science study will address the following:
Formative question: What are the strengths and weaknesses of the four models for case identification, confirmation and referral currently being implemented in Liberia for NTDs?
Intervention question: What is the optimal model for implementing case identification, confirmation and referral of NTD cases requiring case management, in terms of equity, effectiveness, economy and efficiency within the health system?"
Comparison of ICT and FST.
A total of 2,956 samples were investigated simultaneously via ICT cards and FTS - representative of the population of six health districts that had conducted five rounds of MDA for lymphatic filariasis.
- The multi-country studies on the same topic led to the endorsement by WHO for the FTS as an approved diagnostic tool.
Complete mapping of NTDs in AFRO. Support transitioning of new diagnostics tools into program use. (Refer to 23.1, 23.2, 23.3, 23.4, 23.5, 23.6, 23.7, 23.8, 23.9, 23.10.)
Binax Now Filariasis Test vs. Alere Filariasis Test Strip Comparison
Comparison of 2X vs. 1X per year MDA on W. bancrofti with MDA of IVM/Alb, plus STH evaluation (and Schistosoma in Foya only)